AzTrials
AzTrials

HealthyPhase 1/2NCT06237530

Interoception and Body Scan

A Phase 1/2 study testing Visceral body scan (VBS) and Somatosensory body scan (SBS) in people with Healthy, run by University of Valencia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Body scan meditation has been assumed to be an interoceptive intervention, and the evidence for its effects on interoceptive processes is unclear. Although this mindfulness based exercise typically involves focusing on some interoceptive signals such as breath, it also involves other bodily cues, such as somatosensory… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Visceral body scan (VBS) and Somatosensory body scan (SBS)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
48 participants
Where
1 siteSpain
Study dates
26 Jul 2023to 21 Aug 2023
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age over 18
  • being Spanish or English speakers
  • Ability to use a computer or smartphone
  • Daily access to computer or smartphone with an Internet connection

Who cannot join

  • Being diagnosed with a severe psychiatric disorder (e.g., substance abuse, eating disorder, psychotic disorder)
  • Severe visual or auditory difficulties that cannot be corrected with glasses or auditory aids
  • Having a medical condition that prevents participation in this study
  • Changes in psychotropic medication during the study
  • Having been exposed to any extremely traumatic event that is being re-experienced or interfering during the last month
  • Body image-related difficulties as indicated by scores above 3 on the Body Image as Source of Shame questionnaire.
  • Regular meditation practice in the current moment

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Faculty of Psychology and Speech Therapy, University of Valencia

    Valencia, Valencia, 46010

Other trials in Spain

About this study

Official title: Exploring Visceral Body Scan, Somatosensory Body Scan, and External Meditation

Body scan meditation has been assumed to be an interoceptive intervention, and the evidence for its effects on interoceptive processes is unclear. Although this mindfulness based exercise typically involves focusing on some interoceptive signals such as breath, it also involves other bodily cues, such as somatosensory cues. The present study aimed to (1) investigate the feasibility of three online delivered mindfulness practices that differ in the signals targeted: visceral body scan (VBS), somatosensory body scan (SBS), and external (non body) meditation (ECM), and (2) gain insight into the potentially different effects of these interventions on interoceptive and other psychological outcomes in order to inform future full scale randomized controlled trials (RCT).

Conditions
Healthy
Being tested
Visceral body scan (VBS), Somatosensory body scan (SBS), External control meditation (ECM)
Keywords
body scan, interoception, interoceptive, mindfulness, somatosensory

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Visceral body scan (VBS)Behavioural

    Also called Interoceptive body scan, Interoceptive meditation practice

    The VBS consisted of a mindfulness exercise designed to bring awareness to visceral sensations in the cardiac, respiratory, gastrointestinal, and urinary systems. These physiological systems were chosen because most of the paradigms developed in the literature to assess interoception focus on them (Khalsa et al., and they are widely recognized in the literature as interoceptive senses (Nord \& Garfinkel, 2022)

  • Somatosensory body scan (SBS)Behavioural

    Also called Exteroceptive body scan, Somatosensory meditation practice

    The SBS consisted of a mindfulness exercise designed to bring awareness to tactile (e.g., itching) and musculoskeletal (e.g. g., tension) sensations in different parts of the body, namely, the head and neck, back, arms, and legs. Body scan exercises typically focus on these types of bodily cues (in addition to breathing) (Williams, 2010).

  • External control meditation (ECM)Behavioural

    Also called Non-body meditation practice, Visual and auditory mindfulness exercise

    The ECM consisted of a mindfulness exercise designed to bring awareness to external stimuli, including sounds and visual properties of the environment.

Study groups in NCT06237530
Study groupRoleWhat they receive
Visceral Body Scan (VBS)ExperimentalThe VBS consisted of a mindfulness exercise designed to bring awareness to visceral sensations in the cardiac, respiratory, gastrointestinal, and urinary systems. These physiological systems were chosen because most of the paradigms developed in the literature to assess interoception focus on them (Khalsa et al., and they are widely recognized in the literature as interoceptive senses (Nord \& Garfinkel, 2022)
Receives: Behavioral: Visceral body scan (VBS)
Somatosensory body scan (SBS)Active comparatorThe SBS consisted of a mindfulness exercise designed to bring awareness to tactile (e.g., itching) and musculoskeletal (e.g. g., tension) sensations in different parts of the body, namely, the head and neck, back, arms, and legs. Body scan exercises typically focus on these types of bodily cues (in addition to breathing) (Williams, 2010).
Receives: Behavioral: Somatosensory body scan (SBS)
External control meditation (ECM)Sham comparatorThe ECM consisted of a mindfulness exercise designed to bring awareness to external stimuli, including sounds and visual properties of the environment
Receives: Behavioral: External control meditation (ECM)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence assessed by completed intervention sessions

    Percentage of completed daily sessions during the 7-day intervention

    Measured: Through study completion, a total of 7 days

  2. Meditation-related adverse effects assessed by a self-report questionnaire

    Meditation-Related Adverse Effect Scale - Mindfulness-Based Program. It includes 11 dichotomic items (yes/no questions), so scores ranges from 0 to 11, with higher scores indicating more adverse effects

    Measured: Immediately post-intervention

  3. Acceptability assessed by a satisfaction questionnaire

    Treatment Satisfaction Scale. It includes 5 items rated on Likert-point scale ranging from 0 to 10. Thus, total scores range from 0 to 50, with higher scores indicating greater acceptability of the intervention

    Measured: Immediately post-intervention

  4. Self-reported quality of the mindfulness practice

    Practice Quality-Mindfulness. It consists of 6 items rated on a visual analogue scale ranging from 0 to 100, with higher scores reflecting a higher level of practice quality.

    Measured: Immediately post-intervention

Secondary outcomes (10)
  1. Adaptive interoceptive sensibility style assessed by a questionnaire

    Multidimensional Assessment of Interoceptive Awareness-2. It consists of 37 items rated on a 6-point Likert scale, with higher values indicating a more adaptive and healthier interoceptive sensibility style (healthier approach to internal bodily signals).

    Measured: Immediately pre-intervention and immediately post-intervention

  2. Sensitivity and attention to interoceptive signals assessed by a questionnaire

    Interoceptive Sensitivity and Attention Questionnaire. It consists of 17 items rated on a 5-point Likert scale, ranging from 1 (totally disagree) to 5 (totally agree). Higher scores reflect greater sensitivity to bodily sensations

    Measured: Immediately pre-intervention and immediately post-intervention

  3. Perceived Body Boundaries in bodily self-awareness assessed by a VAS

    Perceived Body Boundaries Scale. It is visual analogue scale that depicts seven human bodies, ranging from almost imperceptible at the left pole (labeled "my body boundaries are almost imperceptible") to extremely salient at the right pole (labeled my body boundaries are extremely salient"). Scores can range from 0 to 15.5, with higher scores indicating greater salience in perceiving body boundaries.

    Measured: Immediately pre-intervention and immediately post-intervention

  4. Spatial Frame of Reference in bodily self-awareness assessed by a VAS

    Spatial Frame of Reference Continuum. It is a visual analogue scale depicting five concentric circles surrounding the outline of a human figure, and individuals are asked to indicate how far they feel that their self extends beyond their physical body. Scores range from 1 to 6, with higher scores reflecting a more allocentric (vs. egocentric) frame of reference.

    Measured: Immediately pre-intervention and immediately post-intervention

  5. Mindfulness trait assessed by a self-report questionnaire

    Short form of the Five Facet Mindfulness Questionnaire. It is a 15-item instrument that measures the tendency to be mindful in daily life. Items are rated on a 5-point Likert scale, from 1 (never or very rarely true) to 5 (very often or always true). It includes the following dimensions: observing, describing, acting with awareness, non judging internal experience, and non reactivity to internal experience. Higher scores indicate higher levels of the corresponding mindfulness dimension.

    Measured: Immediately pre-intervention and immediately post-intervention

  6. Alexithymia assessed by a self-report questionnaire

    The Perth Alexithymia Questionnaire Questionnaire-Short Form. It includes 7 items rated on a 7-point Likert scale (1=strongly disagree; 7=strongly agree), with higher scores indicating higher levels of alexithymia

    Measured: Immediately pre-intervention and immediately post-intervention

  7. Negative emotion regulation assessed by a self-report questionnaire

    Short-form version of the Difficulties in Emotion Regulation Scale. It is an 18 item questionnaire that measures the degree of difficulty in regulating emotions. Items are rated on a 5 point Likert scale, ranging from 1 (almost never) to 5 almost always). It includes the following dimensions: (1) lack of emotional awareness of one's own emotions; (2) self reported difficulty in completing tasks and concentrating in the presence of negative emotions; (3) limited access to regulatory strategies that the in dividual perceives as effective; (4) nonacceptance of negative emotional states; (5) self reported difficulty in controlling one's behavior in the presence of negative emotional states, and (6) lack of emotional clarity, i.e., limited knowledge and clarity about one's emotional states. Higher scores indicate higher difficulties in regulating emotions.

    Measured: Immediately pre-intervention and immediately post-intervention

  8. Positive emotion regulation assessed by a self-report questionnaire

    Responses to Positive Affect Questionnaire. It is a 16 item questionnaire that measures responses to positive moods, including dampening (i.e., thoughts that are likely to dampen positive emotional states), self focused positive rumination (i.e., rumination on aspects of the self and the pursuit of goals relevant to the self), and emotion focused positive rumination (i.e., rumination on positive mood). Items are rated on a 4 point Likert scale, ranging from 1 almost never ) to 4 almost always ), with higher scores reflecting a greater use of such strategy.

    Measured: Immediately pre-intervention and immediately post-intervention

  9. Depressive symptomatology assessed by a self-report questionnaire

    Patient Health Questionnaire-9. It consists of 9 items, which are rated on a 4-point Likert scale, ranging from 0 (never) to 4 (almost every day). Higher scores indicate greater severity of depressive symptoms.

    Measured: Immediately pre-intervention and immediately post-intervention

  10. Qualitative feedback assessed by several open-ended questions

    Ad-hoc open-ended questions: ended questions: (1) "Do you think that participating in this study has helped you learn something or become aware of something? If so, what did you learn?"; (2) Do you think that doing the meditation practice has helped you improve anything? If so, what benefits have you noticed noticed?"; (3) Does this practice make sense to you, and why? "; (4) Please describe the sensations, thoughts and/or feelings you have had while doing the meditation practice "; (5) What difficulties have you found when doing the meditation practice?"; (6) What did you like most about the meditation practice? And what did you like the least?", and (7) What do you think is the objective or hypothesis of the study?".

    Measured: Immediately pre-intervention and immediately post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2024
  2. Study start26 Jul 2023
  3. Primary completion21 Aug 2023
  4. Study completion21 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The investigators tested two different versions of the body scan (meditation practice), one focused on visceral signals -visceral body scan (VBS)- and the other on somatosensory signals -somatosensory body scan (SBS)- in comparison to an exteroceptive, non-body focused, control condition -external control meditation (ECM)-. To do so, an online approach was conducted, as it has been proved to be an effective strategy, while being more widely accessible and reducing costs and time.
Masking
Single blind
Who is masked
Participant
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06237530
Sponsor's protocol ID
2569173
Status last verified
Jan 2024
First submitted
4 Dec 2023
Last updated
1 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Visceral body scan (VBS) and Somatosensory body scan (SBS) in people with Healthy, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence assessed by completed intervention sessions (time frame: Through study completion, a total of 7 days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Interoception and Body Scan (NCT06237530) | AzTrials